Derrick Hall of the Arizona Diamondbacks is honorary chair of TGen's 10th annual stepNout race Nov. 1

5K is expected to draw record numbers of participants to the Scottsdale Sports Complex, helping fund TGen's pancreatic cancer research

SCOTTSDALE, Ariz. - Oct. 5, 2015 - What started as a small fundraiser for the Translational Genomics Research Institute (TGen) has blossomed over the past decade into one of Arizona's largest annual events in the fight to conquer cancer.

TGen's 10th annual stepNout Run Walk Dash on Nov. 1 at the Scottsdale Sports Complex is expected to draw a record crowd and raise record donations for TGen's fight against the ravages of pancreatic cancer, the nation's fourth leading cause of cancer related death.

This 10th anniversary event includes special commemorative t-shirts, food trucks, music, games, a photo booth, a balloon artist, face painting and more. Form a team with your family or employees where you work. Raise more than $1,500 and earn a team tent and team photo. Participants may sign up by going to and clicking on Events.

Last year, TGen's stepNout raised nearly $250,000, bringing total donations since 2006 to more than $1 million. This year, stepNout begins efforts to raise another $1 million.

"Support from the stepNout event and the Seena Magowitz Foundation has helped our team devise a treatment, which has already improved survival of patients with pancreatic cancer," said TGen Physician-In-Chief Dr. Daniel D. Von Hoff. "The new therapies we are currently offering to patients look even more promising."

We cannot accomplish our goal together of taking out this disease without support like this, said Dr. Von Hoff.

For the second year, Arizona Diamondbacks President and CEO Derrick Hall will be the honorary chair of stepNout.

"It is my honor to participate again this year in TGen's stepNout," said Hall, who lost his father to pancreatic cancer nearly four years ago. "It is my hope that together we can all make a difference in the struggle to find new ways of detecting this disease early and of finding new treatments to better the lives of patients and their families."

The pancreas is an organ that sits behind the stomach and is responsible for producing hormones and digestive juices. Pancreatic cancer this year will take the lives of more than 40,000 Americans. Median survival for patients with advanced disease was less than 6 months, and the 5-year survival rate was less than 10 percent. Thanks to fundraising efforts like this, both of these statistics are now improving.

Under Dr. Von Hoff's leadership, TGen - in cooperation with HonorHealth - has made major progress in treating patients with pancreatic cancer. Based on TGen's science, followed by a major clinical trial, the FDA in 2013 approved the use of albumin-bound paclitaxel (Abraxane) in combination with gemcitabine as a front-line therapy for patients with advanced pancreatic cancer.

"We are grateful to the hundreds of generous friends whose participation in this event has helped establish TGen as a world leader in pancreatic cancer research," said TGen Foundation President Michael Bassoff. "The stepNout event brings real hope to patients and families worldwide."

More than 1,000 people are expected to participate in competitive races for all ages and abilities, including the event's signature 5K run. Onlineregistration ends Oct. 27 butparticipants can stillregister at the event. This is the second year the event will be at the Scottsdale Sports Complex, northeast of Bell and Hayden roads.


If you go to stepNout

What: TGen's 10th annual stepNout Run/Walk/Dash for pancreatic cancer research.

Where: Scottsdale Sports Complex, 8081 E. Princess Drive, northeast of Hayden and Bell roads, between Loop 101 and Frank Lloyd Wright Boulevard.

When: 7:30-11 a.m. Sunday, Nov. 1. Registration starts at 7:30 a.m.; races begin at 9 a.m.; a kids' dash is planned for 10:30 a.m.

Cost: Registration fees range from $10 to $30, depending on age. Costs increase by $5 after Oct. 16. Children ages 4 and under are free.

Parking: Free.
More information and registration: and click on events. Contact Andrea Daly at (602) 343-8572 or by email at [email protected].

# # #

About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, Follow TGen on Facebook, LinkedIn and Twitter @TGen.

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

Media Contact

RSS Feed